Frontiers in Oncology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 22 Feb 2024

Identification and validation of a gap junction protein related signature for predicting the prognosis of renal clear cell carcinoma

in Pharmacology of Anti-Cancer Drugs

Yongsheng Huang
Wenyi Guo
Yuan Zeng
Xinrong Wang
Bohao Fan
Ying Zhang
Lei Yan
Gangli Gu
Zhao Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1354049

3,026 views

Original Research

Published on 22 Feb 2024

The efficacy of furmonertinib in untreated advanced NSCLC patients with sensitive EGFR mutations in a real-world setting: a single institutional experience

in Pharmacology of Anti-Cancer Drugs

Ningning Yan
Sanxing Guo
Siyuan Huang
Huixian Zhang
Xingya Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1331128

3,512 views
1 citation

Case Report

Published on 22 Feb 2024

Aplastic anemia secondary to adjuvant Osimertinib therapy: a case report and a review of literature

in Pharmacology of Anti-Cancer Drugs

Ahmed Abdalhadi
Nabil E. Omar
Samah Kohla
Hassan Aakel
Yeslem Ekeibed
Reyad Mohsen

Frontiers in Oncology

doi 10.3389/fonc.2024.1275275

2,726 views
3 citations

Case Report

Published on 15 Feb 2024

Case report: A rare case of triple negative breast cancer with development of acute pancreatitis due to dexamethasone during adjuvant chemotherapy

in Pharmacology of Anti-Cancer Drugs

Hirofumi Ohmura
Taro Tobo
Yuki Ando
Takaaki Masuda
Koshi Mimori
Koichi Akashi
Eishi Baba

Frontiers in Oncology

doi 10.3389/fonc.2024.1340419

2,270 views
1 citation

Original Research

Published on 15 Feb 2024

Platinum-based neoadjuvant chemotherapy upregulates STING/IFN pathway expression and promotes TILs infiltration in NSCLC

in Pharmacology of Anti-Cancer Drugs

Huan Gao
Xiaoni Zhang
Mengdi Ren
Aimin Jiang
Na Liu
Jingjing Wang
Xiaoqiang Zheng
Xuan Liang
Zhiping Ruan
Tao Tian

Frontiers in Oncology

doi 10.3389/fonc.2024.1346225

1,987 views

Review

Published on 12 Feb 2024

Therapeutic biomarkers in acute myeloid leukemia: functional and genomic approaches

in Pharmacology of Anti-Cancer Drugs

Karanpreet Bhatia
Vedant Sandhu
Mei Hsuan Wong
Prasad Iyer
Shruti Bhatt

Frontiers in Oncology

doi 10.3389/fonc.2024.1275251

5,008 views
6 citations

Brief Research Report

Published on 02 Feb 2024

PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancer

in Pharmacology of Anti-Cancer Drugs

Norman Fultang
Ashley M. Schwab
Sophia McAneny-Droz
Alexander Grego
Stephanie Rodgers
Brian Vidal Torres
Diane Heiser
Peggy Scherle
Neha Bhagwat

Frontiers in Oncology

doi 10.3389/fonc.2024.1343004

3,564 views
2 citations

Original Research

Published on 29 Jan 2024

Aluminium phthalocyanine-mediated photodynamic therapy induces ATM-related DNA damage response and apoptosis in human oesophageal cancer cells

in Pharmacology of Anti-Cancer Drugs

Onyisi Christiana Didamson
Rahul Chandran
Heidi Abrahamse

Frontiers in Oncology

doi 10.3389/fonc.2024.1338802

2,934 views
5 citations

Review

Published on 29 Jan 2024

Pediatric oncology drug development and dosage optimization

in Pharmacology of Anti-Cancer Drugs

S. Y. Amy Cheung
Justin L. Hay
Yu-Wei Lin
Rik de Greef
Julie Bullock

Frontiers in Oncology

doi 10.3389/fonc.2023.1235947

4,738 views
4 citations

Review

Published on 18 Jan 2024

Regulated cell death in glioma: promising targets for natural small-molecule compounds

in Pharmacology of Anti-Cancer Drugs

Mingyu Han
Sui Li
Huali Fan
Junsha An
Cheng Peng
Fu Peng

Frontiers in Oncology

doi 10.3389/fonc.2024.1273841

4,611 views
12 citations

Original Research

Published on 11 Jan 2024

Bibliometric and visual analysis in the field of tea in cancer from 2013 to 2023

in Pharmacology of Anti-Cancer Drugs

Yuanchu Lian
Xiating Li
Ying Lan
Zonghuai Li
Xiaoxin Lin
Jing’an Huang
Bo Zhang
Zhongwen Feng

Frontiers in Oncology

doi 10.3389/fonc.2023.1296511

2,287 views
5 citations

Editorial

Published on 04 Jan 2024

Editorial: Metal nanoparticles in cancer: detection, diagnosis, therapy and their pharmacological assessment

in Pharmacology of Anti-Cancer Drugs

Massimiliano Peana
Alexandros G. Georgakilas

Frontiers in Oncology

doi 10.3389/fonc.2023.1344197

1,126 views
3 citations

Original Research

Published on 03 Jan 2024

Formoterol reduces muscle wasting in mice undergoing doxorubicin chemotherapy

in Pharmacology of Anti-Cancer Drugs

Edson Alves de Lima Junior
Alexandre Abilio de Souza Teixeira
Loreana Sanches Silveira
Queralt Jové
Natalia Álvarez Ladrón
Marcelo G. Pereira
Francisco Javier López-Soriano
Josep M. Argilés
Patrícia Chakur Brum
Silvia Busquets

Frontiers in Oncology

doi 10.3389/fonc.2023.1237709

2,288 views
1 citation

Review

Published on 19 Dec 2023

Active components of Solanum nigrum and their antitumor effects: a literature review

in Pharmacology of Anti-Cancer Drugs

Han Zhang
Jun-lin Lv
Qiu-sheng Zheng
Jie Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1329957

5,629 views
6 citations

Review

Published on 13 Dec 2023

Critical review of the current and future prospects of VEGF-TKIs in the management of squamous cell carcinoma of head and neck

in Pharmacology of Anti-Cancer Drugs

Prashant Puttagunta
Saagar V. Pamulapati
James E. Bates
Jennifer H. Gross
William A. Stokes
Nicole C. Schmitt
Conor Steuer
Yong Teng
Nabil F. Saba

Frontiers in Oncology

doi 10.3389/fonc.2023.1310106

3,749 views
3 citations

Review

Published on 12 Dec 2023

The renal damage and mechanisms relevant to antitumoral drugs

in Pharmacology of Anti-Cancer Drugs

Jiyu Tang
Nan Yang
Shujun Pan
Peiyao Ren
Maosheng Chen
Juan Jin
Qiang He
Yuqun Zeng

Frontiers in Oncology

doi 10.3389/fonc.2023.1331671

2,613 views
5 citations